撒哈拉以南非洲儿童和年轻成人中的非自身免疫性胰岛素缺乏型糖尿病:来自非洲年轻起病糖尿病(YODA)横断面研究的证据
该观察性横断面研究在喀麦隆、乌干达和南非纳入894例临床诊断的年轻起病胰岛素治疗型1型糖尿病患者,仅34.9%胰岛自身抗体阳性;抗体阴性者1型糖尿病遗传风险评分显著低于抗体阳性者,提示存在非自身免疫性胰岛素缺乏型糖尿病亚型,美国SEARCH研究中黑人 ancestry 也有类似模式而白人无。
要点
- 撒哈拉以南非洲临床诊断的1型糖尿病中仅34.9%(312/894)胰岛自身抗体阳性。
- 抗体阴性者1型糖尿病遗传风险评分中位数9.66,显著低于抗体阳性者的11.76(p<0.0001)。
- 美国SEARCH研究中黑人 ancestry 年轻起病者亦见抗体阴性亚型且遗传风险评分低,白人无此模式。
核心结论
- 撒哈拉以南非洲临床诊断的1型糖尿病具有异质性,包括经典自身免疫性1型糖尿病和一种新的非自身免疫性胰岛素缺乏型糖尿病亚型。
- 美国黑人个体中存在该亚型的证据,而白人个体中未观察到此模式。
- 作者认为在该人群中必须考虑其他病因,理解该亚型的驱动因素可能为预防和治疗提供新见解。
研究设计与样本
- 观察性横断面研究,在喀麦隆、乌干达和南非的政府及私立医院门诊识别自我报告为非洲黑人族群、年轻起病(年龄<30岁)、胰岛素治疗、临床诊断1型糖尿病且无肥胖的参与者。
- 检测胰岛自身抗体(GADA、IA-2A、ZnT8A),计算1型糖尿病遗传风险评分(GRS),并与来自乌干达基因组资源数据库和其他研究的无糖尿病对照人群比较。
- 用血浆C肽评估内源性胰岛素分泌,并与美国SEARCH for Diabetes in Youth研究中自我报告为黑人(n=429)和白人(n=2602) ancestry 的1型糖尿病参与者的发现进行比较。
主要发现
- 2019年8月28日至2022年3月31日(喀麦隆和乌干达)及2007年10月3日至2015年9月14日(南非)识别1072例参与者,894例纳入分析(男性454例[50.8%],女性440例[49.2%]):喀麦隆248例,乌干达370例,南非276例。
- 撒哈拉以南非洲参与者诊断糖尿病的中位年龄为15岁(IQR 11-19),中位糖尿病病程5年(2-10),BMI为21.7 kg/m2(19.5-24.1)。
- 894例中仅312例(34.9%)胰岛自身抗体阳性;这些参与者具有经典1型糖尿病特征,包括272例中225例(82.7%)血浆C肽<200 pmol/L,且1型糖尿病GRS高。
- 无胰岛自身抗体的582例(65.1%)1型糖尿病GRS中位数显著低于有抗体者(9.66 [IQR 7.77-11.33] vs 11.76 [10.49-12.91];p<0.0001),提示存在非自身免疫性糖尿病亚型,其临床特征和C肽浓度与2型糖尿病不一致。
- 在诊断年龄<20岁的参与者中,SEARCH研究中黑人 ancestry 的429例里也有65例(15.1%)为抗体阴性糖尿病(虽然频率低于撒哈拉以南非洲的107例中59例[55.1%]),且这些参与者1型糖尿病GRS也低(抗体阴性亚组中位数10.41 [IQR 8.65-12.22]);SEARCH白人参与者中未观察到此模式:2602例中241例(9.3%)抗体阴性,抗体阴性与抗体阳性者1型糖尿病GRS中位数相似(13.42 [IQR 11.80-14.61] vs 13.49 [12.29-14.58])。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies of type 1 diabetes in sub-Saharan Africa have suggested that the clinical phenotype might differ from phenotypes reported elsewhere. We aimed to establish whether type 1 diabetes diagnosed in children and young adults in three countries across sub-Saharan Africa is of autoimmune origin. METHODS: In this observational, cross-sectional study, we identified participants without obesity from outpatient clinics in government and private hospitals in Cameroon, Uganda, and South Africa who were of self-reported Black African ethnicity with young-onset (age <30 years), insulin-treated, clinically diagnosed type 1 diabetes. We measured islet autoantibodies to GADA, IA-2A, and ZnT8A, and calculated a genetic risk score (GRS) for type 1 diabetes, which we compared with control populations without diabetes derived from the Uganda Genome Resource databank and other studies. Endogenous insulin secretion was assessed using plasma C-peptide. We compared findings with those for participants with self-reported Black (n=429) and White (n=2602) ancestry with type 1 diabetes from the SEARCH for Diabetes in Youth (SEARCH) study in the USA. FINDINGS: Of 1072 participants identified between Aug 28, 2019, and March 31, 2022 (Cameroon and Uganda), and Oct 3, 2007, to Sept 14, 2015 (South Africa), 894 were included in our analysis (454 [50·8%] were male and 440 [49·2%] were female): 248 participants were from Cameroon, 370 from Uganda, and 276 from South Africa. Participants from sub-Saharan Africa were diagnosed with diabetes at a median age of 15 years (IQR 11-19), with a median diabetes duration of 5 years (2-10), and a BMI of 21·7 kg/m2 (19·5-24·1). Only 312 (34·9%) of 894 participants were positive for islet autoantibodies; these participants had classic features of type 1 diabetes, including 225 (82·7%) of 272 with plasma C-peptide <200 pmol/L, and high type 1 diabetes GRS. Those without islet autoantibodies (582 [65·1%] of 894) had significantly lower median type 1 diabetes GRS than those with autoantibodies (9·66 [IQR 7·77-11·33] vs 11·76 [10·49-12·91]; p<0·0001), suggesting a subgroup with a non-autoimmune diabetes subtype, with clinical features and C-peptide concentrations not consistent with type 2 diabetes. Among participants diagnosed younger than 20 years, autoantibody-negative diabetes was also observed in 65 (15·1%) of 429 participants with Black ancestry in SEARCH (although less frequently than in sub-Saharan Africa [59 (55·1%) of 107]), and these participants also had a low type 1 diabetes GRS (median 10·41 [IQR 8·65-12·22] in autoantibody-negative subgroup). No such pattern was observed in White participants in SEARCH: 241 (9·3%) of 2602 were autoantibody negative and median GRS for type 1 diabetes was similar in autoantibody-negative and autoantibody-positive participants (median 13·42 [IQR 11·80-14·61] vs 13·49 [12·29-14·58]). INTERPRETATION: In sub-Saharan Africa, clinically diagnosed type 1 diabetes is heterogeneous, comprising classic autoimmune type 1 diabetes and a novel, non-autoimmune, insulin-deficient diabetes subtype. There is evidence of this subtype in Black but not White individuals in the USA. Therefore, alternative causes must be considered in this group of individuals, and understanding the drivers of this subtype might offer new insights into prevention and treatment. FUNDING: UK National Institute of Health and Care Research. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.
引用
- Katte JC, Squires S, Dehayem MY, et al. Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study. Lancet Diabetes Endocrinol. 2025. PMID: 40706606. doi:10.1016/S2213-8587(25)00120-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。